Paragon: FDA’s Lack Of AI Knowledge Endangers Regulatory Schema

FDA’s lack of in-house expertise on artificial intelligence and machine learning is one of the biggest challenges to effective AI regulation by the agency and risks outsourcing regulatory decisions to biased private entities through assurance labs, the conservative health care think tank Paragon Health Institute argues in a report released this month. The report notes that there is not a comprehensive framework for regulating AI in health care and agencies like FDA face issues like a lack of internal programming...